pharmaphorum

DECEMBER 21, 2020

The European Commission has already approved the drug under the brand name Leqvio earlier this month following backing from the CHMP regulatory committee. The FDA has not yet conducted a facility inspection and the FDA will set out a schedule if it deems one necessary, once safe travel may resume.

Drugs 52

Drugs RNA Manufacturing Licensing 52

XTalks

JANUARY 25, 2021

Patients in the studies were virologically suppressed (HIV-1 RNA less than 50 copies/milliliter) prior to initiation of treatment with Cabenuva. Since then, Cabenuva received its first global approval in Canada in March 2020, followed by authorization in the EU in December under two separate brand names. Opening up Options.

FDA Approval 52

FDA Approval Trials Clinical Trials Clinical Trials 52

pharmaphorum

APRIL 28, 2022

But the company was inspired to re-brand its rare disease business unit as a response to internal ramp-ups that have occurred over the last few years, Helfgott said. Plus, many of these small players are very good at research, not necessarily at developing or commercialising their brands,” he said.

Pharma Companies 59

Pharma Companies Branding Development Marketing 59

The Pharma Data

JANUARY 21, 2021

Cabotegravir is a ViiV product marketed as Cabenuva, and rilpivirine is a Janssen product with a brand name Edurant. ViiV Healthcare focuses on HIV and is majority-owned by GlaxoSmithKline (GSK), with Pfizer and Shionogi Limited as shareholders. Janssen is a Johnson & Johnson company.

FDA Approval 52

FDA Approval Clinical Trials Clinical Trials Trials 52

Pharma Marketing Network

DECEMBER 21, 2020

those that modify the expression of an individual’s genes or repair abnormal genes) has entered clinical practice, including 11 RNA therapeutics, 2 in vivo gene therapies, and 2 gene-modified cell therapies. For example, “gene silencing” is a less-than-ideal description for the mechanism of RNA interference (RNAi) therapeutics.

Genetics 52

Genetics Medicine Gene Therapy Marketing 52

The Pharma Data

JANUARY 22, 2021

As research developments into RNA vaccines help scientists accelerate drug candidates to arm the immune system against coronavirus, Pharma IQ ’s Keeping tabs on Covid-19 update returns with news from some of the biotechnology innovators leading the fight against the global pandemic. Download this exclusive report here.

Vaccination 52

Vaccination Vaccine Protein Immune Response 52

The Pharma Data

JANUARY 6, 2021

Bayer is committed to the principles of sustainable development, and the Bayer brand stands for trust, reliability and quality throughout the world. At the same time, the Group aims to increase its earning power and create value through innovation and growth. In fiscal 2019, the Group employed around 104,000 people and had sales of 43.5

Vaccination 52

Vaccination Vaccine Development Production 52

Roots Analysis

JANUARY 28, 2024

Not only in healthcare, but various industries have also adopted big data to enhance their capabilities, improve customer experiences, and strengthen their brand reputation, thereby contributing to overall growth of the company. This project highlights her ability to navigate the complex intersection of science and finance.

Big Data 40

Big Data Medicine Marketing Clinical Trials 40

XTalks

AUGUST 30, 2022

Such therapies may involve small interfering RNA (siRNA) or oligonucleotides in viral transfection platforms, large molecules and antibodies. Biogen’s nusinersen (brand name Spinraza) is an antisense oligonucleotide (ASO) therapy that is administered directly into the CNS by intrathecal injection through lumbar puncture.

Trials 83

Trials Drug Delivery Drugs Gene 83

Pharmaceutical Technology

OCTOBER 28, 2022

To demonstrate bioequivalence for a generic small molecule drug, a company must carry out a Phase I clinical trial in healthy individuals to ensure that the area under the curve and maximum plasma concentration for their drug is equivalent to that of the brand name drug. For biosimilars, however, this process is slightly more complex.

Bioequivalency 130

Bioequivalency Production Contamination Branding 130

pharmaphorum

JANUARY 6, 2021

Pharma companies are always talking about moving ‘beyond the pill’, and Pfizer’s new brand identity embodies that – it’s decades old pill-like logo has been replaced with a DNA double helix that it says reflects its commitment to breakthrough science. Encoded within a successful emblem is a company’s DNA – its history, its future.

DNA 116

DNA Branding Vaccine Vaccination 116

Scienmag

SEPTEMBER 30, 2020

Scientists are fighting back with multiple strategies, including vaccines, repurposed drugs developed for other diseases and brand-new therapies. Now, researchers reporting in ACS Central Science have identified small molecules that target a structure within the RNA genome […].

RNA 40

RNA Genomics Genome Branding 40

BioTech 365

JUNE 28, 2021

Kate Cronin to Join Moderna as Chief Brand Officer on July 12 Kate Cronin to Join Moderna as Chief Brand Officer on July 12 CAMBRIDGE, Mass.–(BUSINESS Nasdaq: MRNA) a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, … Continue reading → –(BUSINESS WIRE)–Moderna, Inc.,

Branding 40

Branding RNA Vaccination Vaccine 40

Delveinsight

JANUARY 8, 2021

HDV is nothing but a defective RNA virus, a satellite of the helper Hepatitis B virus (HBV) that needs the HBsAg of the hepatitis B virus (HBV) for virion assembly, release, and transmission. Recently, the Europe commission approved Bulevirtide (brand name Hepcludex) for the treatment of Hepatitis D after decades of research and trials.

Marketing 52

Marketing RNA Development Pharma Companies 52

The Pharma Data

AUGUST 30, 2021

As the first and only small interfering RNA to provide effective and sustained LDL-C reduction, Leqvio helps manage a critical cardiovascular risk factor for ASCVD. Leqvio is the first and only approved small interfering RNA (siRNA) LDL-C-lowering treatment in Europe 6,7. Product and brand name are currently under FDA review.

RNA 52

RNA Trials Production Containment 52

The Pharma Data

MAY 13, 2021

Because right now, I’m going to share something BRAND-NEW, backed by mountains of scientific research which will help to treat your pain. For example, studies done on Red Light show it: Because right now, I’m going to share something BRAND-NEW, backed by mountains of scientific research which will help to treat your pain.

Production 52

Production Pharmacy Doctors Doctor 52

XTalks

SEPTEMBER 14, 2020

The company’s candidate vaccine, mRNA-1273, is a synthetic messenger RNA that encodes the stabilized SARS-CoV-2 spike protein. Meanwhile, don’t chalk one up for Sanofi, who makes the branded formulation (Plaquenil) of hydroxychloroquine (HCQ). Fujifilm Favipiravir (Avigan) Inhibits RNA-dependent RNA polymerase.

Vaccine 92

Vaccine Vaccination Antibody Life Science 92